MeSH D014945 - wound healing
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Johnson & Johnson | Becaplermin | Regranex | 1999-03-29 |
Clinical Trials
Historical Success Rate
Phase 1
20%1/5
Phase 2
67%4/6
Phase 3
29%2/7
Approved: 2Overall Success rate: 4%
All Clinical Trials
No data
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use